Skip to content

ENDURANT® ENBF2516C145ERecalls & reported problems

Medtronic, Inc. · STENT GRAFT ENBF2516C145E ENDURANT BIF · Class 3 · Implant

All models of ENDURANT (46)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
1
Injuries reported
5
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00613994762238), received between Jun 16, 2017 and Feb 6, 2024 — classified as 1 death, 5 injuries.

The most frequently reported specific device problem is “Leak/Splash” (5 reports).

6 other recalls cover devices cleared under the same FDA submission (P100021); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 1 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Leak/Splash5
  • Adverse Event Without Identified Device or Use Problem1
  • Malposition of Device1

Patient problems

  • Insufficient Information3
  • Injury2
  • Calcium Deposits/Calcification1
  • Death1
  • Hemorrhage/Blood Loss/Bleeding1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 6, 2024Leak/Splash; Leak/Splash

    AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A 106MM AAA. IT WAS REPORTED THAT A CT WAS TAKEN APPROXIMATELY 13 YEARS POST THE INDEX PROCEDURE SHOWED A TYPE IA ENDOLEAK. IT WAS NOTED THAT THE PATIENT HAD A NON-MDT CUFF AND LIMBS PRESENT WITHIN THE ENDURANT GRAFT WHICH WERE IMPLANTED ON AN UNKNOWN DATE. THE ENDURANT STENT GRAFTS AND NON-MDT STENT GRAFTS WERE EXPLANTED. THE PATIENTS CONDITION IS POST THE EXPLANT PROCEDURE WAS NOTED AS ALIVE AND WELL. PER THE PHYSICIAN THE CAUSE OF THE ENDOLEAK WAS ANATOMY RELATED AND DUE TO AORTIC NECK DEGENERATION. NO ADDITIONAL SEQUELAE WERE REPORTED AND THE PATIENTS IS FINE.

    Patient problems: Insufficient Information

    MAUDE report 18650650 ↗
  • InjuryAug 10, 2022Leak/Splash; Leak/Splash

    AN ENDURANT BIFURCATE STENT GRAFT SYSTEM WAS IMPLANTED IN THE ENDOVASCULAR TREATMENT OF A  AAA.  IT WAS REPORTED WHEN THE PATIENT RETURNED FOR FOLLOW-UP , A TYPE IA ENDOLEAK WAS NOTED ON CTA.  PER THE PHYSICIAN THE CAUSE OF THE EVENT IS ANATOMY AND AORTIC NECK DILATION OVER TIME.  NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 15202311 ↗
  • InjurySep 14, 2021Leak/Splash; Leak/Splash

    AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN THE PATIENT FOR THE ENDOVASCULAR TREATMENT OF AN APPROX. 60MM MM ABDOMINAL AORTIC ANEURYSM. ENDOLEAK TYPE 1A WAS OBSERVED ON A FOLLOW-UP VISIT ON AN UNKNOWN DATE (APPROX. 10 YEARS LATER). A CUFF WAS PLACED TO RESOLVE THE ISSUE. IT WAS REPORTED DURING THE INTERVENTION THE DEVICE CAUGHT ON THE SUPRA RENAL STENTS MAKING THE STENT GRAFT PUSH UP WHILE THE PHYSICIAN WAS TRYING TO RETRIEVE THE DEVICE. IT WAS REPORTED THE DELIVERY SYSTEM WAS VERY DIFFICULT TO RETRIEVE OR ADVANCE AS PER THE PHYSICIAN THE CAUSE OF THE EVENT CAN NOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUALAE WERE REPORTED AND THE PATIENT IS FINE.

    Patient problems: Insufficient Information

    MAUDE report 12465879 ↗
  • InjuryJul 25, 2018Leak/Splash

    AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 50MM DIAMETER ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT APPROXIMATELY 5 YEARS POST INDEX PROCEDURE, THE PATIENT PRESENTED AT FOLLOW UP WITH A TYPE IA ENDOLEAK. INTERVENTION WAS COMPLETED WITH THE PLACEMENT OF ENDOANCHORS AND BALLOON ANGIOPLASTY AND THE ENDOLEAK RESOLVED. PER THE PHYSICIAN THE CAUSE OF THE EVENT WAS ANATOMY RELATED DUE TO THE EXCESS CALCIFICATION PRESENT. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED, AND THE PATIENT IS FINE.

    Patient problems: Calcium Deposits/Calcification; Hemorrhage/Blood Loss/Bleeding; Injury

    MAUDE report 7717635 ↗
  • InjurySep 1, 2017Leak/Splash; Malposition of Device; Leak/Splash; Malposition of Device

    AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 55MM DIAMETER ABDOMINAL AORTIC ANEURYSM. THE AORTIC NECK WAS 23MM IN DIAMETER AND 15MM IN LENGTH WITH 10 DEGREE ANGULATION. IT WAS REPORTED THAT A CT ON AN UNKNOWN DATE SHOWED THERE WAS AN ENDOLEAK. IT WAS ALSO NOTED THAT THE STENT GRAFT WAS LANDED LOW AT THE TIME OF THE ORIGINAL IMPLANT AND WITH THE DISEASE PROGRESSING PROXIMALLY IT CREATED AN ENDOLEAK. THE PHYSICIAN PLACED A 25MM DIAMETER AORTIC CUFF AND 6 ENDOANCHORS AND THE ENDOLEAK WAS RESOLVED. PER THE PHYSICIAN THE CAUSE OF THE EVENT WAS DUE TO THE STENT GRAFT BEING PLACED LOW ORIGINALLY. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.

    Patient problems: Injury

    MAUDE report 6837311 ↗
  • DeathJun 16, 2017Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    AN ENDURANT STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR ENDOVASCULAR TREATMENT OF AN ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT THE PATIENT EXPIRED ON AN UNKNOWN DATE OF AN UNKNOWN CAUSE. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED.

    Patient problems: Death

    MAUDE report 6647748 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P100021. One submission often covers many models, so check the product and lot details in each record.

  • Z-0292-2022 · Oct 15, 2021 · Open, Classified
    Endurant IIs Stent Graft System REF/Description: ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STEN
  • Z-0290-2022 · Oct 15, 2021 · Open, Classified
    Endurant Stent Graft System REF/Description: ENTF2525C70EE STENT GRAFT ENTF2525C70EE ENDURANT TUBE
  • Z-0291-2022 · Oct 15, 2021 · Open, Classified
    Endurant II Stent Graft System REF/Description: ETBF2513C145EE STENT GRAFT ETBF2513C145EE ENDUR II BIF ETBF2820C166EE STENT GRAFT ETBF2820C166EE ENDUR II BIF ETBF2820C166EE STENT G
  • Z-2136-2021 · Jun 7, 2021 · Open, Classified
    Medtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aort
  • Z-2135-2021 · Jun 7, 2021 · Open, Classified
    Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat i
  • Z-1543-2017 · Feb 27, 2017 · Terminated
    Endurant / Endurant II 23mm and 25mm Bifurcated Stent Graft Systems Model Numbers: ETBF2516C145E ETBF2516C166E ETBF2316C145E ETBF2313C145E ETBF2513C166E ETBF2313C166E ETBF2316C166

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page